Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trimethoprim/sulfamethoxazole prophylaxis for Pneumocystis jirovecii pneumonia in B-cell lymphoma patients receiving chemotherapy
TCTR20191025002Phase 3Not yet recruiting
- Sponsor
- Faculty of Medicine Siriraj Hospital, Mahidol University
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of trimethoprim + sulfamethoxazole in pneumocystis pneumonia (PCP), sponsored by Faculty of Medicine Siriraj Hospital, Mahidol University. Planned start Dec 2019; status: not yet recruiting.
02
Drugs
trimethoprim + sulfamethoxazole
03
Conditions
pneumocystis pneumonia (PCP)
Beyond the preview
Go deeper on TCTR20191025002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20191025002.